Article info

other Versions

PDF
Extended report
Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study

Authors

  • Elena Nikiphorou Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands Academic Rheumatology Department, King’s College London, London, UK PubMed articlesGoogle scholar articles
  • Désirée van der Heijde Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Sam Norton Academic Rheumatology Department, King’s College London, London, UK PubMed articlesGoogle scholar articles
  • Robert BM Landewé Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam, The Netherlands and Zuyderland Medical Center, Heerlen, The Netherlands PubMed articlesGoogle scholar articles
  • Anna Molto Department of Rheumatology, Paris Descartes University, Department of Rheumatology - Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris, France PubMed articlesGoogle scholar articles
  • Maxime Dougados Department of Rheumatology, Paris Descartes University, Department of Rheumatology - Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris, France PubMed articlesGoogle scholar articles
  • Filip E Van den Bosch VIB Inflammation Research Center, Ghent University, Ghent, Belgium Department of Rheumatology, Ghent University Hospital, Ghent, Belgium PubMed articlesGoogle scholar articles
  • Sofia Ramiro Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Google scholar articles
  1. Correspondence to Dr Elena Nikiphorou, Academic Rheumatology Department, King’s College London, Weston Education,Denmark Hill,SE1 1UL, UK; enikiphorou{at}gmail.com
View Full Text

Citation

Nikiphorou E, van der Heijde D, Norton S Collaborators, et al
Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study

Publication history

  • Received September 28, 2017
  • Revised October 25, 2017
  • Accepted November 8, 2017
  • First published December 8, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.